Cargando…
A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447692/ https://www.ncbi.nlm.nih.gov/pubmed/30725205 http://dx.doi.org/10.1007/s00262-019-02308-w |
| _version_ | 1783408549207998464 |
|---|---|
| author | Suarez-Kelly, Lorena P. Levine, Kala M. Olencki, Thomas E. del Campo, Sara E. Martin Streacker, Elizabeth A. Brooks, Taylor R. Karpa, Volodymyr I. Markowitz, Joseph Bingman, Anissa K. Geyer, Susan M. Kendra, Kari L. Carson, William E. |
| author_facet | Suarez-Kelly, Lorena P. Levine, Kala M. Olencki, Thomas E. del Campo, Sara E. Martin Streacker, Elizabeth A. Brooks, Taylor R. Karpa, Volodymyr I. Markowitz, Joseph Bingman, Anissa K. Geyer, Susan M. Kendra, Kari L. Carson, William E. |
| author_sort | Suarez-Kelly, Lorena P. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6447692 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-64476922019-04-17 A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma Suarez-Kelly, Lorena P. Levine, Kala M. Olencki, Thomas E. del Campo, Sara E. Martin Streacker, Elizabeth A. Brooks, Taylor R. Karpa, Volodymyr I. Markowitz, Joseph Bingman, Anissa K. Geyer, Susan M. Kendra, Kari L. Carson, William E. Cancer Immunol Immunother Clinical Trial Report Springer Berlin Heidelberg 2019-02-06 2019 /pmc/articles/PMC6447692/ /pubmed/30725205 http://dx.doi.org/10.1007/s00262-019-02308-w Text en © The Author(s) 2019 |
| spellingShingle | Clinical Trial Report Suarez-Kelly, Lorena P. Levine, Kala M. Olencki, Thomas E. del Campo, Sara E. Martin Streacker, Elizabeth A. Brooks, Taylor R. Karpa, Volodymyr I. Markowitz, Joseph Bingman, Anissa K. Geyer, Susan M. Kendra, Kari L. Carson, William E. A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma |
| title | A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma |
| title_full | A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma |
| title_fullStr | A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma |
| title_full_unstemmed | A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma |
| title_short | A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma |
| title_sort | pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma |
| topic | Clinical Trial Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447692/ https://www.ncbi.nlm.nih.gov/pubmed/30725205 http://dx.doi.org/10.1007/s00262-019-02308-w |
| work_keys_str_mv | AT suarezkellylorenap apilotstudyofinterferonalpha2bdosereductionintheadjuvanttherapyofhighriskmelanoma AT levinekalam apilotstudyofinterferonalpha2bdosereductionintheadjuvanttherapyofhighriskmelanoma AT olenckithomase apilotstudyofinterferonalpha2bdosereductionintheadjuvanttherapyofhighriskmelanoma AT delcamposaraemartin apilotstudyofinterferonalpha2bdosereductionintheadjuvanttherapyofhighriskmelanoma AT streackerelizabetha apilotstudyofinterferonalpha2bdosereductionintheadjuvanttherapyofhighriskmelanoma AT brookstaylorr apilotstudyofinterferonalpha2bdosereductionintheadjuvanttherapyofhighriskmelanoma AT karpavolodymyri apilotstudyofinterferonalpha2bdosereductionintheadjuvanttherapyofhighriskmelanoma AT markowitzjoseph apilotstudyofinterferonalpha2bdosereductionintheadjuvanttherapyofhighriskmelanoma AT bingmananissak apilotstudyofinterferonalpha2bdosereductionintheadjuvanttherapyofhighriskmelanoma AT geyersusanm apilotstudyofinterferonalpha2bdosereductionintheadjuvanttherapyofhighriskmelanoma AT kendrakaril apilotstudyofinterferonalpha2bdosereductionintheadjuvanttherapyofhighriskmelanoma AT carsonwilliame apilotstudyofinterferonalpha2bdosereductionintheadjuvanttherapyofhighriskmelanoma AT suarezkellylorenap pilotstudyofinterferonalpha2bdosereductionintheadjuvanttherapyofhighriskmelanoma AT levinekalam pilotstudyofinterferonalpha2bdosereductionintheadjuvanttherapyofhighriskmelanoma AT olenckithomase pilotstudyofinterferonalpha2bdosereductionintheadjuvanttherapyofhighriskmelanoma AT delcamposaraemartin pilotstudyofinterferonalpha2bdosereductionintheadjuvanttherapyofhighriskmelanoma AT streackerelizabetha pilotstudyofinterferonalpha2bdosereductionintheadjuvanttherapyofhighriskmelanoma AT brookstaylorr pilotstudyofinterferonalpha2bdosereductionintheadjuvanttherapyofhighriskmelanoma AT karpavolodymyri pilotstudyofinterferonalpha2bdosereductionintheadjuvanttherapyofhighriskmelanoma AT markowitzjoseph pilotstudyofinterferonalpha2bdosereductionintheadjuvanttherapyofhighriskmelanoma AT bingmananissak pilotstudyofinterferonalpha2bdosereductionintheadjuvanttherapyofhighriskmelanoma AT geyersusanm pilotstudyofinterferonalpha2bdosereductionintheadjuvanttherapyofhighriskmelanoma AT kendrakaril pilotstudyofinterferonalpha2bdosereductionintheadjuvanttherapyofhighriskmelanoma AT carsonwilliame pilotstudyofinterferonalpha2bdosereductionintheadjuvanttherapyofhighriskmelanoma |